Skip to Content

Goldman Sachs Small/Mid Cap Value A GMVAX

Medalist Rating as of | See Goldman Sachs Investment Hub
  • NAV / 1-Day Return 15.48  /  +1.44 %
  • Total Assets 145.8 Mil
  • Adj. Expense Ratio
    1.170%
  • Expense Ratio 1.170%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Mid-Cap Blend
  • Investment Style Small Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.57%
  • Turnover 56%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 12:21 AM GMT+0

Morningstar’s Analysis GMVAX

Will GMVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Goldman Sachs Small/ Mid Cap Value A earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GMVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Goldman Sachs FS Government Instl

1.91 3.0 Mil
Cash and Equivalents

Curtiss-Wright Corp

1.70 2.6 Mil
Industrials

Saia Inc

1.65 2.6 Mil
Industrials

Tenet Healthcare Corp

1.60 2.5 Mil
Healthcare

Entegris Inc

1.47 2.3 Mil
Technology

AECOM

1.45 2.2 Mil
Industrials

Regal Rexnord Corp

1.44 2.2 Mil
Industrials

KBR Inc

1.39 2.2 Mil
Industrials

SPX Technologies Inc

1.38 2.1 Mil
Industrials

ASGN Inc

1.28 2.0 Mil
Technology